ASX Announcements


 
    Change in substantial holding  
 
    Appendix 3Y - Anna Lavelle  
 
    Appendix 3Y - Albert Hansen  
 
    Appendix 3Y - David Brookes  
 
    Cleansing Notice  
 
    Application for quotation of securities - ILA  
 
    Results of Annual General Meeting  
 
    Annual General Meeting MD Presentation  
 
    Annual General Meeting Chair Address  
 
    ISLA-101 Phase 2a clinical trial update  
 
    Quarterly Activity Report & Appendix 4C  
 
    Change in substantial holding  
 
    Proposed issue of securities - ILA  
 
    Annual Report to shareholders  
 
    Letter to Shareholders & Notice of Annual General Meeting  
 
    Change in substantial holding  
 
    Updated Investor Presentation  
 
    Release of Securities from Voluntary Escrow  
 
    Date of AGM & Closing Date for Director Nominations  
 
    Island updates API agreement  
 
    Appendix 4G  
 
    Corporate Governance Statement  
 
    Appendix 4E & Annual Report  
 
    Griffith Uni Anti-Viral Molecule Screening Collaboration  
 
    Change in substantial holding  
 
    Island granted key Australian patent for ISLA-101  
 
    Becoming a substantial holder  
 
    Quarterly Activity Report & Appendix 4C  
 
    Island secures API - shortens timeline to clinical trials  
 
    ASEAN Dengue Day - Investor briefing notification  
 
    Island Pharmaceuticals granted key United States patent  
 
    Island lists on the ASX following oversubscribed IPO  
 
    Island Pharmaceuticals IPO Investor Presentation  
 
    Appendix 3X - Anna Lavelle  
 
    Appendix 3X - David Brookes  
 
    Appendix 3X - Paul MacLeman  
 
    Appendix 3X - David Foster  
 
    Appendix 3X - Albert Hansen  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Pre-Quotation Disclosure Statement  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Securities Trading Policy  
 
    U.S. Option Terms  
 
    Option Terms  
 
    Employee Option Terms  
 
    Employee Incentive Plan Rules  
 
    Financial Report 30 June 2020  
 
    Financial Report half year ended 31 December 2020  
 
    Isla Pharmaceuticals, Inc. Financial Report 31 Dec 20 & 19  
 
    Isla Pharmaceuticals, Inc. Financial Report 31 December 2018  
 
    Constitution  
 
    Prospectus  
 
    Appendix 1A and Information Form and Checklist  
 
    Admission and Commencement of Official Quotation